Results 211 to 220 of about 502,065 (385)

Development of a physiologically‐based pharmacokinetic model for Ritonavir characterizing exposure and drug interaction potential at both acute and steady‐state conditions

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 523-539, March 2025.
Abstract Ritonavir (RTV) is a potent CYP3A inhibitor that is widely used as a pharmacokinetic (PK) enhancer to increase exposure to select protease inhibitors. However, as a strong and complex perpetrator of CYP3A interactions, RTV can also enhance the exposure of other co‐administered CYP3A substrates, potentially causing toxicity.
Lien Thi Ngo   +5 more
wiley   +1 more source

Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment

open access: yesJournal of the American Medical Association (JAMA), 2017
S. Resnick   +25 more
semanticscholar   +1 more source

An Open‐Source Framework for Virtual Bioequivalence Modeling and Clinical Trial Design

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT To establish bioequivalence (BE) of a generic test formulation with respect to a reference listed drug, it is necessary to demonstrate a comparable rate and extent to which active ingredients reach the site of action. To decrease unnecessary human testing and simulate scenarios involving specific populations or challenges with recruitment or ...
Abdullah Hamadeh   +13 more
wiley   +1 more source

Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes. [PDF]

open access: yesCureus
Pinto da Costa Viana D   +6 more
europepmc   +1 more source

A Population Pharmacokinetic Approach to Understand the Effect of Efavirenz on CYP3A Activity in Healthy Volunteers Using Midazolam as a Probe

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Efavirenz induces and inhibits multiple drug‐metabolizing enzymes, contributing to significant drug–drug interactions. This study quantified the impact of multiple doses of efavirenz on CYP3A activity via midazolam metabolism using a population pharmacokinetic approach.
Kimberly S. Collins   +6 more
wiley   +1 more source

SYNTHESIS AND METABOLIC STUDIES OF 17-METHYL-C14-TESTOSTERONE

open access: hybrid, 1954
Paul M. Hyde   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy